Status:
COMPLETED
To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
Lead Sponsor:
Pfizer
Conditions:
Diabetic Neuropathy, Painful
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate the safety and efficacy of pregabalin in patients with painful diabetic peripheral neuropathy.
Eligibility Criteria
Inclusion
- Must have met the inclusion criteria for the preceding double-blind BID study in painful diabetic peripheral neuropathy
- Must have received pregabalin/placebo under double-blind conditions for a minimum of 3 weeks.
Exclusion
- Patients may not participate if they experienced a serious adverse event during the preceding double-blind BID study which was determined to be related to the study medication.
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT00150423
Start Date
January 1 2001
End Date
July 1 2005
Last Update
January 1 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.